24 March 2022

The Nagoya Protocol: why it increasingly matters to the life sciences community

It’s been over seven years since the Nagoya Protocol (Nagoya) on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity entered into force.

Whilst users of biological materials overwhelmingly support the idea of protecting biodiversity and benefit-sharing, compliance with national laws around the world (including the UK) seeking to implement Nagoya is disproportionately cumbersome, with confusing and uncertain regulatory frameworks.

Despite the uncertainty brought about by Nagoya and its adverse impact on R&D in the engineering biology, biotech and pharma sectors, international efforts to broaden the scope of Nagoya to regulate use of digital sequence information are gathering momentum.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk